Clean Open Trials Public List 01 Feb 16-2.docx

Clean Open Trials Public List 01 Feb 16-2.docx - Northern...

This preview shows 1 out of 3 pages.

Northern Ireland Cancer Trials Network Belfast Experimental Cancer Medicine Centre Trials Open to Recruitment – February 2016 Anal Cancer InterAACT An International Multicentre Open Label Randomised Phase II Advanced Anal Cancer Trial Comparing Cisplatin plus 5-fluorouracil (5-FU) versus Carboplatin plus Weekly Paclitaxel in Patients with Inoperable Locally Recurrent or Metastatic Disease Bladder HABIO Haematuria Biomarker Study (also available in Ulster and Craigavon Hospital) Bowel Cancer NSCCG National Study Of Colorectal Cancer Genetics (also available in Altnagelvin, Antrim, Craigavon and Ulster Hospitals) MERCURY 2 Low Rectal Cancer Study (only available at the Ulster Hospital) ARISTOTLE A phase III trial comparing standard versus novel CRT as pre- operative treatment for MRI defined locally advanced rectal cancer (also available in Craigavon Hospital) CREST The role of endoluminal stenting in the acute management of obstructing colorectal cancer (only available at the Ulster Hospital) MErCuRIC 1 A Phase I study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in RAS MT and RAS WT (with aberrant c-MET) Colorectal Cancer Patients Breast Cancer DDRD In Breast Cancer: A Biomarker Phase Study In Patients Receiving Neoadjuvant Chemotherapy 1
Image of page 1

Subscribe to view the full document.

POSNOC PO sitive S entinel NO de: adjuvant therapy alone versus adjuvant therapy plus C learance or axillary radiotherapy. A randomised controlled trial of axillary treatment in women with early stage breast cancer who have metastases in one or two sentinel nodes PAKT A Phase II, Double-Blind, Randomised, Placebo-Controlled Study Of the AKT Inhibitor AZD5363 In Combination With Pacltaxel In Triple-Negative Advanced Or Metastatic Breast Cancer Olympia A randomised, double-blind, parallel group, placebo-controlled multi- centre Phase III study to assess the efficacy and safety of olaparib versus placebo as adjuvant treatment in patients with germline BRCA1/2 mutations and high risk HER2 negative primary breast cancer who have completed definitive local treatment and neoadjuvant or adjuvant chemotherapy. DBT Digital breast tomosynthesis (DBT): Sensitivity for cancer and accuracy in assessing extent of malignant disease in symptomatic women below 60 with clinical or ultrasound signs compatible with malignancy MAMMO-50 Mammographic surveillance in breast cancer patients aged 50 years or older (also available in Craigavon) PALLET A phase II randomised study evaluating the biological and clinical effects of the combination of palbociclib with letrozole as neoadjuvant therapy in post-menopausal women with ER+ primary breast cancer BRAVO A phase III, randomized, open label, multicenter, controlled trial of niraparib versus physician's choice in previously-treated, HER2 negative, germline BRCA mutation-positive breast cancer patients.
Image of page 2
Image of page 3
You've reached the end of this preview.
  • Summer '17
  • Ahmed Bukhari
  • Prostate cancer, Cancer Patients, breast cancer patients, National Study Of Colorectal Cancer Genetics

{[ snackBarMessage ]}

What students are saying

  • Left Quote Icon

    As a current student on this bumpy collegiate pathway, I stumbled upon Course Hero, where I can find study resources for nearly all my courses, get online help from tutors 24/7, and even share my old projects, papers, and lecture notes with other students.

    Student Picture

    Kiran Temple University Fox School of Business ‘17, Course Hero Intern

  • Left Quote Icon

    I cannot even describe how much Course Hero helped me this summer. It’s truly become something I can always rely on and help me. In the end, I was not only able to survive summer classes, but I was able to thrive thanks to Course Hero.

    Student Picture

    Dana University of Pennsylvania ‘17, Course Hero Intern

  • Left Quote Icon

    The ability to access any university’s resources through Course Hero proved invaluable in my case. I was behind on Tulane coursework and actually used UCLA’s materials to help me move forward and get everything together on time.

    Student Picture

    Jill Tulane University ‘16, Course Hero Intern